• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ(PPARγ)的激活可抑制人胃癌细胞的生长并诱导其凋亡。

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.

作者信息

Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y

机构信息

Third Department of Internal Medicine, Asahikawa Medical College, Japan.

出版信息

FEBS Lett. 1999 Jul 16;455(1-2):135-9. doi: 10.1016/s0014-5793(99)00871-6.

DOI:10.1016/s0014-5793(99)00871-6
PMID:10428487
Abstract

We investigated the expression of peroxisome proliferator-activated receptor gamma (PPARgamma) and the role of PPARgamma in cell growth in human gastric cancer cells. Reverse transcription-polymerase chain reaction, Northern blot and Western blot analyses showed that a human gastric cancer cell line, MKN45, expressed PPARgamma mRNA and protein. Luciferase assay in MKN45 cells showed that troglitazone, a selective ligand for PPARgamma, transactivated the transcription of a peroxisome proliferator response element-driven promoter. Troglitazone or pioglitazone, selective ligands for PPARgamma, inhibited the growth of MKN45 cells in a dose-dependent manner. Co-incubation of MKN45 cells with troglitazone induced DNA ladder formation. These results suggest that human gastric cancer cells express PPARgamma and that activation of PPARgamma inhibits cell growth and induces apoptosis in gastric cancer cells.

摘要

我们研究了过氧化物酶体增殖物激活受体γ(PPARγ)的表达及其在人胃癌细胞生长中的作用。逆转录-聚合酶链反应、Northern印迹和Western印迹分析表明,人胃癌细胞系MKN45表达PPARγ mRNA和蛋白。MKN45细胞中的荧光素酶测定表明,PPARγ的选择性配体曲格列酮可反式激活过氧化物酶体增殖物反应元件驱动的启动子的转录。曲格列酮或吡格列酮作为PPARγ的选择性配体,以剂量依赖的方式抑制MKN45细胞的生长。MKN45细胞与曲格列酮共同孵育可诱导DNA梯带形成。这些结果表明,人胃癌细胞表达PPARγ,PPARγ的激活可抑制胃癌细胞的生长并诱导其凋亡。

相似文献

1
Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.过氧化物酶体增殖物激活受体γ(PPARγ)的激活可抑制人胃癌细胞的生长并诱导其凋亡。
FEBS Lett. 1999 Jul 16;455(1-2):135-9. doi: 10.1016/s0014-5793(99)00871-6.
2
Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.曲格列酮激活过氧化物酶体增殖物激活受体γ通过增加人胰腺癌细胞中p27KiP1来抑制细胞生长。
Cancer Res. 2000 Oct 1;60(19):5558-64.
3
A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.过氧化物酶体增殖物激活受体γ的一种配体可抑制人肝癌细胞的生长并诱导其凋亡。
Gut. 2002 Apr;50(4):563-7. doi: 10.1136/gut.50.4.563.
4
Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.曲格列酮通过诱导p27(Kip1)导致G1期阻滞,这是由抑制人胃癌细胞中的蛋白酶体介导的。
Jpn J Cancer Res. 2002 Jul;93(7):774-82. doi: 10.1111/j.1349-7006.2002.tb01319.x.
5
Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.过氧化物酶体增殖物激活受体(PPAR)γ在胃癌中的表达及PPARγ激动剂的抑制作用。
Br J Cancer. 2000 Nov;83(10):1394-400. doi: 10.1054/bjoc.2000.1457.
6
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells.过氧化物酶体增殖物激活受体γ配体对胃癌细胞生长及基因表达谱的影响
Gut. 2004 Mar;53(3):331-8. doi: 10.1136/gut.2003.021105.
7
Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.过氧化物酶体增殖物激活受体γ在人涎腺癌细胞系中的表达及其合成配体的生长抑制作用
Int J Oncol. 2002 Mar;20(3):599-605.
8
The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells.过氧化物酶体增殖物激活受体γ(PPARγ)配体对人黑色素瘤细胞增殖和凋亡的影响。
Melanoma Res. 2003 Oct;13(5):447-56. doi: 10.1097/00008390-200310000-00003.
9
Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.曲格列酮诱导的生长停滞是由p27Kip1蓄积介导的,其源于对人肝癌细胞中蛋白酶体活性和Skp2表达的双重抑制。
Int J Cancer. 2004 Jan 1;108(1):41-6. doi: 10.1002/ijc.11561.
10
Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.过氧化物酶体增殖物激活受体γ(PPARγ)配体诱导结肠癌细胞凋亡的特征。
Gut. 2002 May;50(5):658-64. doi: 10.1136/gut.50.5.658.

引用本文的文献

1
Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas.全面分析过氧化物酶体增殖物激活受体以预测胃腺癌的耐药性、免疫微环境和预后。
PeerJ. 2024 Mar 22;12:e17082. doi: 10.7717/peerj.17082. eCollection 2024.
2
Inhibition of PI3K Signaling Intensified the Antileukemic Effects of Pioglitazone: New Insight into the Application of PPARγ Stimulators in Acute Lymphoblastic Leukemia.抑制PI3K信号通路增强了吡格列酮的抗白血病作用:对PPARγ激动剂在急性淋巴细胞白血病中应用的新见解。
Indian J Hematol Blood Transfus. 2023 Oct;39(4):546-556. doi: 10.1007/s12288-023-01650-5. Epub 2023 Apr 1.
3
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.
过氧化物酶体增殖物激活受体与癌症的特征。
Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432.
4
Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors.基于结构生物学的过氧化物酶体增殖物激活受体亚型选择性激动剂研究
Int J Mol Sci. 2021 Aug 26;22(17):9223. doi: 10.3390/ijms22179223.
5
The herbal agent plantamajoside, exerts a potential inhibitory effect on the development of hepatocellular carcinoma.草药成分大车前苷对肝细胞癌的发展具有潜在的抑制作用。
Exp Ther Med. 2021 Jun;21(6):573. doi: 10.3892/etm.2021.10005. Epub 2021 Mar 31.
6
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients.COX-2/PPARγ联合表达作为外阴癌患者独立的负性预后因素
Diagnostics (Basel). 2021 Mar 10;11(3):491. doi: 10.3390/diagnostics11030491.
7
Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells.人A549肺腺癌细胞中PPARγ激活导致终末分化为脂肪细胞并抑制生长。
Anim Cells Syst (Seoul). 2020 Dec 2;24(6):329-340. doi: 10.1080/19768354.2020.1847731.
8
Drug rechanneling: A novel paradigm for cancer treatment.药物重定向:癌症治疗的新范例。
Semin Cancer Biol. 2021 Jan;68:279-290. doi: 10.1016/j.semcancer.2020.03.011. Epub 2020 May 11.
9
Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer.序列相似性83家族成员D表达上调通过激活Wnt/β-连环蛋白信号通路增强细胞增殖和迁移能力,并预示胃癌预后不良。
Cancer Manag Res. 2019 Jul 22;11:6775-6791. doi: 10.2147/CMAR.S203082. eCollection 2019.
10
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists.手性苯氧乙酸类似物作为 PPARγ 部分激动剂抑制结肠癌细胞增殖。
Sci Rep. 2019 Apr 1;9(1):5434. doi: 10.1038/s41598-019-41765-2.